Liquid biopsy·AI·3D printing lift Korea’s platform tech trio[K-bio Pulse] 김승권 2025.12.26 오전 08:00 YooSeok Hong, CEO Genome&Company “Enhancing the Value of GENA-104 for Sub-licensing” 김진수 2025.02.27 오전 10:22 Vigencell Soars on Trial Win; Foreign Buying Lifts Nextbiomedical [K-Bio Pulse] 석지헌 2025.11.28 오전 09:18 SAM CHUN DANG PHARM Tops KOSDAQ…Biotech Rotation Without Flows[K-Bio Pulse] 김새미 2026.03.23 오전 08:00 로딩중..